Pharmacy Focus - Alternative Career Paths in PBMs

Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.

In this week’s episode, we spoke with Matt Gibbs, president of Capital Rx, to discuss alternative career paths in independently owned PBMs.

Related Videos
Portrait of a smiling female pharmacist, male colleague working with drugs in the background. | Image Credit: bnenin - stock.adobe.com
Dermatologist examining the skin of a patient | Image Credit: thodonal - stock.adobe.com
Burnout illustration | Image credit: Vikky Mir - stock.adobe.com
Public Health Matters podcast logo
Capitol Building | Image credit: lazyllama - stock.adobe.com
Related Content

Generic Product News: March 2023

March 28th 2023

Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health

March 24th 2023

Kisqali Phase 3 Trial Meets Primary Endpoint for Patients With Early Breast Cancer

March 28th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

Workforce Shortages Present Serious Challenges

March 28th 2023

Risankizumab Meets Primary Endpoint of Clinical Remission for Moderate to Severe Ulcerative Colitis

March 28th 2023

Generic Product News: March 2023

March 28th 2023

Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health

March 24th 2023

Kisqali Phase 3 Trial Meets Primary Endpoint for Patients With Early Breast Cancer

March 28th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

Workforce Shortages Present Serious Challenges

March 28th 2023

Risankizumab Meets Primary Endpoint of Clinical Remission for Moderate to Severe Ulcerative Colitis

March 28th 2023

Generic Product News: March 2023

March 28th 2023

Pharmacy Focus: Psychedelic Pharmacy - Psychedelics Are Changing the Landscape of Mental Health

March 24th 2023

Kisqali Phase 3 Trial Meets Primary Endpoint for Patients With Early Breast Cancer

March 28th 2023

Independent Rx Forum - Five Trends in Community Pharmacy

March 22nd 2023

Workforce Shortages Present Serious Challenges

March 28th 2023

Risankizumab Meets Primary Endpoint of Clinical Remission for Moderate to Severe Ulcerative Colitis

March 28th 2023
© 2023 MJH Life Sciences

All rights reserved.